Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
38.7M
-
Shares change
-
-1.28M
-
Total reported value, excl. options
-
$145M
-
Value change
-
+$648K
-
Put/Call ratio
-
4.59
-
Number of buys
-
51
-
Number of sells
-
-31
-
Price
-
$3.76
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2020
105 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q4 2020.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.7M shares
.
Largest 10 shareholders include BVF INC/IL (9.54M shares), NEA Management Company, LLC (9.09M shares), BlackRock Inc. (2.62M shares), VANGUARD GROUP INC (2.57M shares), Camber Capital Management LP (2.2M shares), DIMENSIONAL FUND ADVISORS LP (1.21M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (900K shares), ACADIAN ASSET MANAGEMENT LLC (810K shares), TWO SIGMA ADVISERS, LP (788K shares), and TWO SIGMA INVESTMENTS, LP (775K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.